433 related articles for article (PubMed ID: 12620073)
21. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
[TBL] [Abstract][Full Text] [Related]
22. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
[TBL] [Abstract][Full Text] [Related]
23. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
[TBL] [Abstract][Full Text] [Related]
24. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.
Antonini I; Polucci P; Magnano A; Cacciamani D; Konieczny MT; Paradziej-Łukowicz J; Martelli S
Bioorg Med Chem; 2003 Feb; 11(3):399-405. PubMed ID: 12517435
[TBL] [Abstract][Full Text] [Related]
25. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives.
Bacherikov VA; Chang JY; Lin YW; Chen CH; Pan WY; Dong H; Lee RZ; Chou TC; Su TL
Bioorg Med Chem; 2005 Dec; 13(23):6513-20. PubMed ID: 16140018
[TBL] [Abstract][Full Text] [Related]
27. 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.
Plsikova J; Janovec L; Koval J; Ungvarsky J; Mikes J; Jendzelovsky R; Fedorocko P; Imrich J; Kristian P; Kasparkova J; Brabec V; Kozurkova M
Eur J Med Chem; 2012 Nov; 57():283-95. PubMed ID: 23072739
[TBL] [Abstract][Full Text] [Related]
28. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
[TBL] [Abstract][Full Text] [Related]
30. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
[TBL] [Abstract][Full Text] [Related]
31. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
[TBL] [Abstract][Full Text] [Related]
33. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
34. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity.
Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA
J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111
[TBL] [Abstract][Full Text] [Related]
35. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
Yin H; Xu Y; Qian X
Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
[TBL] [Abstract][Full Text] [Related]
36. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
37. Comparative QSAR studies on substituted bis-(acridines) and bis-(phenazines)-carboxamides: a new class of anticancer agents.
Garg R; Denny WA; Hansch C
Bioorg Med Chem; 2000 Jul; 8(7):1835-9. PubMed ID: 10976532
[TBL] [Abstract][Full Text] [Related]
38. Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
Ohara K; Smietana M; Restouin A; Mollard S; Borg JP; Collette Y; Vasseur JJ
J Med Chem; 2007 Dec; 50(26):6465-75. PubMed ID: 18052116
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.
Searcey M; McClean S; Madden B; McGown AT; Wakelin LP
Anticancer Drug Des; 1998 Dec; 13(8):837-55. PubMed ID: 10335263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
